Product Browser

Last updated: 2017/12/10

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

L3MBTL 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00026013-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-L3MBTL full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 85.03
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-L3MBTL antibody (H00026013-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00026013-T01
    L3MBTL transfected lysate.
    Western Blot
    QC Testing of H00026013-T01
    Lane 1: L3MBTL transfected lysate ( 85.03 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Protein Accession#:
  • -
  • Gene Name:
  • L3MBTL
  • Gene Alias:
  • DKFZp586P1522,FLJ41181,H-L(3)MBT,KIAA0681,L3MBTL1,dJ138B7.3
  • Gene Description:
  • l(3)mbt-like (Drosophila)
  • Gene Summary:
  • This gene encodes the homolog of a protein identified in Drosophila as a suppressor of malignant transformation of neuroblasts and ganglion-mother cells in the optic centers of the brain. This gene product is localized to condensed chromosomes in mitotic cells. Overexpression of this gene in a glioma cell line results in improper nuclear segregation and cytokinesis producing multinucleated cells. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq
  • Other Designations:
  • OTTHUMP00000031024,l(3)mbt-like,lethal (3) malignant brain tumor l(3)
  • RSS
  • YouTube
  • Linkedin
  • Facebook